{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:09:51Z","timestamp":1788869391809,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":4821,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.fertnstert.2009.03.081","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T23:33:16Z","timestamp":1241739196000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Adjuncts for ovarian stimulation: when do we adopt \u201corphan indications\u201d for approved drugs?"],"prefix":"10.1016","volume":"92","author":[{"given":"David R.","family":"Meldrum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeffrey","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"de Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Schoolcraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Richard T.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pellicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2009.03.081_bib1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)60553-8","article-title":"Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval","volume":"51","author":"Meldrum","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib3","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0015-0282(98)00333-1","article-title":"Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates","volume":"70","author":"Biljan","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/humrep\/13.3.561","article-title":"Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH)","volume":"13","author":"de Zeigler","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib5","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1093\/humrep\/deg516","article-title":"Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib6","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2007.05.025","article-title":"A luteal estradiol protocol for expected poor-responders improves embryo number and quality","volume":"89","author":"Frattarelli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/humrep\/dei501","article-title":"A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome","volume":"21","author":"Costello","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib9","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0015-0282(02)04242-5","article-title":"Concentration of vascular endothelial growth factor released by cultured luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries","volume":"78","author":"Agrawal","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib10","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0015-0282(02)04244-9","article-title":"Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome","volume":"78","author":"Meldrum","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(00)01766-0","article-title":"Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors","volume":"75","author":"Stadtmauer","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31816a4ed4","article-title":"Use of metformin in polycystic ovary syndrome: a meta-analysis","volume":"111","author":"Creanga","year":"2008","journal-title":"Obstet Gyneco"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","article-title":"Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome","volume":"72","author":"De Leo","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib15","first-page":"1126","article-title":"Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome","volume":"86","author":"Jakubowicz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0015-0282(02)03101-1","article-title":"The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome","volume":"77","author":"Ajossa","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1210\/jc.2002-021072","article-title":"Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome","volume":"88","author":"Cermik","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib18","first-page":"1","article-title":"Growth hormone for in vitro fertilization","volume":"3","author":"Harper","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib19","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0015-0282(97)81862-6","article-title":"Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol","volume":"67","author":"Schoolcraft","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.fertnstert.2005.08.014","article-title":"Apoptosis of cultured granulosa-lutein cells is reduced by insulin-like growth factor I and may correlate with embryo fragmentation and pregnancy rate","volume":"85","author":"Bencomo","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0015-0282(16)47896-9","article-title":"A randomized study of dexamethasone in ovulation induction with clomiphene citrate","volume":"41","author":"Daly","year":"1984","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib23","first-page":"497","article-title":"Clomiphene and dexamethasone in women unresponsive to clomiphene alone","volume":"60","author":"Lobo","year":"1982","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0015-0282(16)58525-2","article-title":"Ovulation induction in clomiphene-resistant anovulatory women with normal dehydroepiandrosterone sulfate levels: beneficial effects of the addition of dexamethasone during the follicular phase","volume":"66","author":"Trott","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(02)04206-1","article-title":"Use of dexamethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial","volume":"78","author":"Parsanezhad","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/humrep\/del053","article-title":"Clomiphene citrate and dexamethasone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study","volume":"21","author":"Elnashar","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib27","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/humrep\/16.9.1861","article-title":"Low-dose dexamethasone augments the ovarian response to exogenous gonadotropins leading to a reduction in cycle cancellation rate in a standard IVF programme","volume":"16","author":"Keay","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib28","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/humrep\/deg322","article-title":"Ovarian modulators of type 1 11beta-hydroxysteroid dehydrogenase (11betaHSD) activity and intra-follicular cortisol:cortisone ratios correlate with the clinical outcome of IVF","volume":"18","author":"Thurston","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib29","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/humrep\/deg352","article-title":"Cortisol and cortisone in human follicular fluid and serum and the outcome of IVF treatment","volume":"18","author":"Lewicka","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0015-0282(16)57354-3","article-title":"Gonadotropin requirements of the developing follicle","volume":"63","author":"Thompson","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0015-0282(99)00426-4","article-title":"Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea","volume":"72","author":"Filicori","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","article-title":"Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay","volume":"71","author":"Rubinstein","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.fertnstert.2006.12.080","article-title":"Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis","volume":"88","author":"Khairy","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib34","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.fertnstert.2004.02.082","article-title":"Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study","volume":"81","author":"Waldenstrom","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.fertnstert.2007.06.033","article-title":"Evidence of absence or absence of evidence? A reanalysis of the effects of low dose aspirin in in vitro fertilization","volume":"90","author":"Ruopp","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib36","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2007-0409","article-title":"Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction","volume":"92","author":"Alverez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib37","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1093\/humrep\/dem315","article-title":"Implantation is apparently unaffected by the dopamine agonist cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study","volume":"22","author":"Alverez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Suissa, S, Haverkamp W, Garbe E. Dopamine agonist and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib40","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/humrep\/del052","article-title":"Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH","volume":"21","author":"Balasch","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of ovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib42","first-page":"629","article-title":"Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function","volume":"24","author":"Barad","year":"2007","journal-title":"J A R G"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib43","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jcem.83.7.4917","article-title":"Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations","volume":"83","author":"Weil","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib44","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/humrep\/dei481","article-title":"Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique\u2014a prospective, randomized, double-blind study","volume":"21","author":"Massin","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2009.03.081_bib45","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209007511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028209007511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:30:29Z","timestamp":1758007829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028209007511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0015028209007511"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.081","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuncts for ovarian stimulation: when do we adopt \u201corphan indications\u201d for approved drugs?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}